Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors (Q37724595)

22 August 2017

1 reference

title

Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors (English)

1 reference

22 August 2017

0 references

1 reference

Klaus Jung

5

1 reference

ORCID Public Data File 2021

author name string

Annika Schaefer

1

1 reference

22 August 2017

Carsten Stephan

2

1 reference

22 August 2017

Jonas Busch

3

1 reference

22 August 2017

George M Yousef

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

6 April 2010

1 reference

22 August 2017

published in

Nature Reviews Urology

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

286-297

1 reference

miRNA, siRNA, piRNA: Knowns of the unknown

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

RISC-target interaction: cleavage and translational suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNAs and their potential for translation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

A microRNA expression ratio defining the invasive phenotype in bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Microarray analysis of microRNA expression in renal clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA profiling of human kidney cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNAs and cancer: current state and future perspectives in urologic oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Role of non-coding RNA and heterochromatin in aneuploidy and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Non-coding RNAs: lost in translation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Long, abundantly expressed non-coding transcripts are altered in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNAs and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Towards the definition of prostate cancer-related microRNAs: where are we now?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNAs and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNAs in clinical oncology: at the crossroads between promises and problems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Many roads to maturity: microRNA biogenesis pathways and their regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Inhibition of translational initiation by Let-7 MicroRNA in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Repression of protein synthesis by miRNAs: how many mechanisms?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Phylogenetic shadowing and computational identification of human microRNA genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Real-time PCR quantification of precursor and mature microRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA expression profiles classify human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

A microRNA expression signature of human solid tumors defines cancer gene targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-cancer connection: the beginning of a new tale

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Regulatory mechanisms of microRNAs involvement in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Identification of let-7-regulated oncofetal genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Circulating microRNAs as stable blood-based markers for cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Detection of cancer with serum miRNAs on an oligonucleotide microarray

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-based therapeutics for cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Silencing of microRNAs in vivo with 'antagomirs'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNAs and cancer epigenetics: a macrorevolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Radiation modulation of microRNA in prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA expression profiling in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Widespread deregulation of microRNA expression in human prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA profile analysis of human prostate cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Loss of mir-146a function in hormone-refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

BMPRII is a direct target of miR-21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-15 and miR-16 induce apoptosis by targeting BCL2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

An E2F/miR-20a autoregulatory feedback loop.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-373 induces expression of genes with complementary promoter sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Up-regulation of microRNA in bladder tumor tissue is not common.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-143 as a tumor suppressor for bladder cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Distinct microRNA alterations characterize high- and low-grade bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Are microRNAs located in genomic regions associated with cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The E2F3-Oncomir-1 axis is activated in Wilms' tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Association of microRNA-34a overexpression with proliferation is cell type-dependent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

High-throughput microRNAome analysis in human germ cell tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Analysis of gene expression in normal and neoplastic human testis: new roles of RNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Widespread changes in protein synthesis induced by microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2010.45

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20368743

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20368743

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRUROL.2010.45

1 reference

22 August 2017

1 reference